RxDoctor Payments Data

Melhem Sharafuddin, MD

Vascular Surgery · Colorado Springs, CONPI 1326118332

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 60.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $14,541 and has fallen 63.9% since, to $5,256 in 2025. Among vascular surgery clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,046in general payments, 2019–2025

Across 85 payments — averaging $541.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$28K
  • Bolton Medical Inc$14K
  • Alphatec Spine, Inc$2K
  • Terumo Medical Corporation$800
  • Shockwave Medical, Inc$591
  • Cook Medical LLC$292
  • plus $517 from 4 others
$1,398,911in research payments, 2019–2025

Across 219 payments — averaging $6387.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$480K
  • Bard Peripheral Vascular, Inc.$202K
  • W. L. Gore & Associates, Inc.$154K
  • Contego Medical, Inc$137K
  • Medtronic$129K
  • Veryan Medical Incorporated$123K
  • plus $173K from 8 others

What the payments were for

  • Consulting fees$27,39159%
  • Speaking & faculty fees$9,65021%
  • Travel & lodging$5,40312%
  • Food & beverage$3,6018%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,046 in reported general payments places this provider in the 90th percentile of 66 vascular surgery providers in Colorado.

See all vascular surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$153,891
Medicare patients
488
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate34$273

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →